May 31-June 03, 2024, Valencia, Spain

European Academy of Allergy and Clinical Immunology (EAACI)

June 09−11, 2023, Hamburg, Germany

European Academy of Allergy and Clinical Immunology (EAACI)

Oral icon

Long-term efficacy and safety of remibrutinib in patients with chronic spontaneous urticaria in the Phase 3 REMIX-1 and REMIX-2 studies

M. Metz, A.M. Giménez-Arnau, M. Hide, V. Jain, A. Khemis, M. Lebwohl, M. Palumbo, S. Saini,
E. Şavk, G. Sussman, R. Szalewski, I. Walecka Herniczek, H. Windom, S. Haemmerle, K. Lheritier, Paula G.P. Machado, E-D. Martzloff, N. Seko, P. Wang, A. Zharkov, M. Maurer
Abstract Oral presentation
Oral icon

Effect of remibrutinib on disease activity in patients with chronic spontaneous urticaria: post hoc analysis of Phase 3 REMIX-1 and REMIX-2 studies

M. Maurer, F. Berard, E. Savk, M. Hide, I.A. Neves, K. Lheritier, N. Chapman-Rothe, S. Haemmerle, A.M. Giménez-Arnau
Abstract Oral presentation
Oral icon

Effect of remibrutinib on sleep and daily activities in patients with chronic spontaneous urticaria: Results from the Phase 3 studies

A.M. Giménez-Arnau, M. Hide, M.Lebwohl, G. Sussman, S. Saini, S. Haemmerle, N. Seko, P. Wang, E-D. Martzloff, M. Maurer
Abstract Oral presentation
Oral icon

Safety of remibrutinib in patients with chronic spontaneous urticaria: Results from the Phase 3 REMIX-1 and REMIX-2 studies​

P. Staubach, S. Saini, A.M. Giménez-Arnau, M. Hide, M. Lebwohl, G. Sussman, S. Haemmerle,
K. Lheritier, E-D. Martzloff, A. Zharkov, M. Maurer
Abstract Poster
Oral icon

Physicians’ prescribing patterns and perceptions of treatments for chronic spontaneous urticaria: Real world data from Urticaria Voices​ study

J.A. Bernstein, K. Weller, M-M.Balp, J. McCarthy, P. Laires, P. Saraswat, T. Raftery, T.A. Winders
Abstract Flash Talk
Oral icon

Worldwide experiences and unmet needs of patients with chronic spontaneous urticaria and treating physicians: The Urticaria Voices study​

T.A. Winders, J.A. Bernstein, M-M. Balp, J. McCarthy, P. Laires, P. Saraswat, T. Raftery, K. Weller
Abstract Flash Talk
Novartis logo
Cookie Settings
© Copyright 2025 Novartis Pharma AG